Incident Report
Subform I: General Information
1. Report Type.
New incident report
Incident Report Number: 2021-6555
2. Registrant Information.
Registrant Reference Number: M-770015-01-1
Registrant Name (Full Legal Name no abbreviations): Bayer CropScience Inc.
Address: Suite 200, 160 Quarry Park Blvd S.E.
City: Calgary
Prov / State: Alberta
Country: Canada
Postal Code: T2C 3G3
3. Select the appropriate subform(s) for the incident.
Scientific Study
4. Date registrant was first informed of the incident.
5. Location of incident.
6. Date incident was first observed.
Product Description
7. a) Provide the active ingredient and, if available, the registration number and product name (include all tank mixes). If the product is not registered provide a submission number.
Active(s)
PMRA Registration No. 31451
PMRA Submission No.
EPA Registration No.
Product Name: BUTEO START 480 FS
PMRA Registration No. 33810
PMRA Submission No.
EPA Registration No.
Product Name: ACCELERON I-425 INSECTICIDE SEED TREATMENT
7. b) Type of formulation.
Application Information
8. Product was applied?
Unknown
9. Application Rate.
10. Site pesticide was applied to (select all that apply).
11. Provide any additional information regarding application (how it was applied, amount applied, the size of the area treated etc).
To be determined by Registrant
12. In your opinion, was the product used according to the label instructions?
Unknown
Subform VII: Scientific Study
1. Study Reference
Title Flupyradifurone FS 480 G:Earthworm (Eisenia fetida) Acute Toxicity Test (Final Report)
Date 03-MAY-21
2. a) Is an extension needed to translate the document?
No
3. Type of incident identified in the study
Increased health or environmental risk
4. Describe the incident identified in the study (e.g. study demonstrates an increased risk to non-Hodgkin's Lymphoma after exposure to pesticide X)
Study performed according to OECD 207 to investigate the potential acute toxicity of Flupyradifurone FS 480 to earthworms.
5. a) Was the study discontinued before completion?
No
5. b) Provide the reason for discontinuation
6. If the study is ongoing, what is the expected completion date?
For Registrant use only
7. Provide supplemental information here
Results of study are not expected to alter risk assessment conclusions.